Index
S&P 500
Market Cap
21.12B
Enterprise Value
28.19B
Income
806.60M
Sales
8.51B
Book/sh
66.23
Cash/sh
2.15
Employees
17000
IPO
Jul 25, 2001
P/E
26.94
Forward P/E
12.22
PEG
2.11
P/S
2.48
P/B
1.67
P/C
51.50
P/FCF
17.60
EV/EBITDA
11.29
EV/Sales
3.31
Quick Ratio
0.94
Current Ratio
1.69
Debt/Eq
0.59
LT Debt/Eq
0.50
Option/Short
Yes / Yes
EPS (ttm)
4.11
EPS next Y
9.06
EPS next Q
2.49
EPS this Y
4.10%
EPS next Y
6.10%
EPS next 5Y
5.79%
EPS past 3/5Y
47.75% -
Sales past 3/5Y
5.85% 3.22%
EPS Y/Y TTM
0.09%
Sales Y/Y TTM
8.62%
EPS Q/Q
33.47%
Sales Q/Q
4.80%
Insider Own
0.18%
Insider Trans
-3.83%
Inst Own
106.61%
Inst Trans
1.14%
ROA
3.53%
ROE
6.42%
ROIC
4.27%
Gross Margin
61.43%
Oper. Margin
16.33%
Profit Margin
9.48%
SMA20
15.71%
SMA50
16.66%
SMA200
20.54%
Trades
Shs Outstand
190.60M
Shs Float
190.40M
52W High
103.70 6.76%
52W Low
79.12 39.93%
Volatility
2.29% 2.35%
ATR (14)
3.32
RSI (14)
75.08
Beta
0.48
Rel Volume
2.39
Avg Volume
2.10M
Volume
2,407,136
Perf Week
14.86%
Perf Month
23.45%
Perf Quarter
13.91%
Perf Half Y
33.66%
Perf YTD
23.12%
Perf Year
7.30%
Perf 3Y
1.80%
Perf 5Y
-17.15%
Perf 10Y
10.79%
Prev Close
97.06
Price
110.71
Change %
14.06%
Analysts 16 incl. previous ratings
Rating Distribution 5 Buy · 10 Hold · 1 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 07, 2026 Initiated B Barclays
Equal Weight $100 -9.7% Jul 28, 2026 Initiated U UBS
Buy $115 +3.9% Jul 09, 2026 Initiated B BMO Capital Markets
Market Perform $95 -14.2% Mar 23, 2026 Downgrade B BTIG Research
Buy → Neutral Feb 20, 2026 Initiated W William Blair
Mkt Perform Jan 09, 2026 Downgrade G Goldman
Neutral → Sell $93 -16.0% Jan 06, 2026 Downgrade R Raymond James
Outperform → Mkt Perform Jan 05, 2026 Upgrade E Evercore ISI
In-line → Outperform $210 +89.7% Dec 16, 2025 Downgrade R Robert W. Baird
Outperform → Neutral $100 -9.7% Nov 06, 2025 Downgrade J JP Morgan
Overweight → Neutral $100 -9.7% Sep 18, 2025 Initiated R Rothschild & Co Redburn
Buy $130 +17.4% Jul 15, 2025 Upgrade R Roth Capital
Neutral → Buy $135 +21.9% Dec 17, 2024 Upgrade J JP Morgan
Neutral → Overweight $125 → $128 +15.6% Sep 10, 2024 Initiated W Wolfe Research
Peer Perform Jul 01, 2024 Downgrade P Piper Sandler
Overweight → Neutral $140 → $115 +3.9% May 30, 2024 Initiated G Goldman
Neutral $129 +16.5% May 21, 2024 Upgrade A Argus
Hold → Buy $150 +35.5% Jan 04, 2024 Downgrade E Evercore ISI
Outperform → In-line $135 → $125 +12.9% Oct 20, 2023 Initiated R ROTH MKM
Neutral $120 +8.4% Aug 28, 2023 Upgrade B BTIG Research
Neutral → Buy $139 +25.6%
Show Previous Ratings
Today 06:36AM
(Associated Press)
+14.06%
06:30AM
Oct-29-26 07:30AM
Oct-27-26 03:11PM
Oct-21-26 08:53AM
05:30AM
Loading…
05:30AM
(The Wall Street Journal)
Oct-13-26 07:30AM
Oct-12-26 04:30PM
Oct-07-26 10:00AM
Oct-06-26 10:02AM
07:30AM
Oct-02-26 04:47AM
Sep-29-26 03:26PM
Sep-28-26 12:49PM
Sep-24-26 02:45PM
11:05AM
Loading…
Sep-21-26 11:05AM
Sep-18-26 08:33AM
Sep-17-26 03:06PM
Sep-14-26 10:34AM
06:00AM
Sep-10-26 01:00AM
Sep-09-26 04:22PM
Sep-08-26 04:30PM
Sep-02-26 03:37PM
Aug-28-26 04:15PM
Aug-27-26 08:12PM
Aug-25-26 11:08AM
Aug-21-26 02:01PM
Aug-12-26 05:37PM
01:20PM
06:13AM
Loading…
Aug-06-26 06:13AM
Aug-05-26 05:05PM
12:15PM
08:57AM
06:36AM
06:30AM
Jul-29-26 09:46AM
Jul-28-26 09:34AM
Jul-24-26 08:47AM
Jul-21-26 02:43PM
Jul-20-26 03:15PM
02:21PM
Jul-16-26 06:00AM
Jul-15-26 02:33PM
Jul-14-26 02:06PM
08:52AM
07:00AM
Jul-13-26 07:30AM
Jul-09-26 09:29AM
Jul-08-26 12:41PM
Jul-06-26 11:31AM
Jul-01-26 06:53AM
Jun-30-26 04:30PM
07:17AM
Jun-23-26 02:11PM
Jun-02-26 07:30AM
May-22-26 04:30PM
May-12-26 04:30PM
06:30AM
May-06-26 07:30AM
Apr-29-26 03:04AM
Apr-28-26 07:02AM
06:35AM
06:30AM
06:29AM
Apr-24-26 03:03AM
Apr-13-26 09:58AM
Apr-09-26 07:30AM
Apr-07-26 07:34AM
07:30AM
Mar-23-26 12:15PM
09:44AM
Mar-16-26 04:57PM
Mar-09-26 01:01AM
Feb-25-26 07:06AM
Feb-23-26 07:00AM
Feb-20-26 09:39AM
Feb-19-26 11:04PM
Feb-18-26 11:01PM
Feb-17-26 12:33AM
Feb-12-26 01:26PM
Feb-11-26 08:04PM
07:55PM
06:41AM
03:57AM
02:07AM
12:31AM
Feb-10-26 12:55PM
12:44PM
11:11AM
09:30AM
08:19AM
07:40AM
06:45AM
06:36AM
(Associated Press Finance)
06:30AM
Feb-09-26 02:08PM
Feb-08-26 10:07PM
Feb-05-26 10:42AM
09:15AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Campbell Gary Craig President, Americas Oct 01 '26 Option Exercise 0.00 3,586 0 2,654 Oct 05 04:12 PM Thornal Kevin R Grp Pres-Global Business Sep 11 '26 Sale 92.95 5,691 528,978 0 Sep 15 04:24 PM Thornal Kevin R Officer Sep 11 '26 Proposed Sale 92.95 5,691 528,978 Sep 11 10:11 AM Phipps Chad F See remarks below. Sep 04 '26 Sale 98.35 3,000 295,050 65,231 Sep 09 04:12 PM Phipps Chad F Officer Sep 04 '26 Proposed Sale 98.35 3,000 295,050 Sep 04 04:01 PM Thornal Kevin R Grp Pres-Global Business Aug 01 '26 Option Exercise 0.00 9,957 0 9,957 Aug 04 04:18 PM Upadhyay Suketu Former Officer Jul 16 '26 Proposed Sale 92.86 7,668 712,050 Jul 16 03:13 PM Upadhyay Suketu Former Officer Jun 24 '26 Proposed Sale 90.07 4,560 410,696 Jun 24 11:46 AM Yi Sang Group President, Asia Pacific May 29 '26 Sale 82.64 5,000 413,216 27,251 Jun 02 04:35 PM Yi Sang Officer May 29 '26 Proposed Sale 82.64 5,000 413,216 May 29 02:21 PM Upadhyay Suketu Former Officer May 19 '26 Proposed Sale 86.38 5,373 464,120 May 19 03:19 PM Upadhyay Suketu Former Officer May 12 '26 Proposed Sale 83.48 31,253 2,608,859 May 12 02:47 PM Noor Jehanzeb See remarks below. Apr 01 '26 Option Exercise 0.00 6,626 0 6,828 Apr 03 04:03 PM Winkler Lori SVP and CHRO Mar 12 '26 Sale 94.66 2,650 250,849 10,224 Mar 16 04:12 PM Winkler Lori Officer Mar 12 '26 Proposed Sale 94.66 2,650 250,836 Mar 12 12:04 PM Upadhyay Suketu Exec VP, CFO Mar 06 '26 Option Exercise 0.00 14,776 0 71,514 Mar 10 04:13 PM VAN ZUILEN WILFRED Group Pres, EMEA Mar 06 '26 Option Exercise 0.00 7,004 0 31,553 Mar 10 04:09 PM Winkler Lori SVP and CHRO Mar 06 '26 Option Exercise 0.00 5,634 0 13,503 Mar 10 04:08 PM Yi Sang Group President, Asia Pacific Mar 06 '26 Option Exercise 0.00 9,414 0 32,251 Mar 10 04:08 PM Stellato Paul A VP, Controller, CAO Mar 06 '26 Option Exercise 0.00 1,970 0 5,890 Mar 10 04:07 PM Phipps Chad F See remarks below. Mar 06 '26 Option Exercise 0.00 6,786 0 68,603 Mar 10 04:06 PM Tornos Ivan Chairman, President and CEO Mar 06 '26 Option Exercise 0.00 34,704 0 92,118 Mar 10 04:03 PM VAN ZUILEN WILFRED Group Pres, EMEA Feb 25 '26 Option Exercise 0.00 3,182 0 26,637 Feb 27 04:07 PM Phipps Chad F See remarks below. Feb 25 '26 Option Exercise 0.00 2,626 0 64,763 Feb 27 04:06 PM Yi Sang Group President, Asia Pacific Feb 25 '26 Option Exercise 0.00 2,785 0 22,837 Feb 27 04:05 PM Winkler Lori SVP and CHRO Feb 25 '26 Option Exercise 0.00 2,347 0 10,342 Feb 27 04:05 PM Upadhyay Suketu Exec VP, CFO Feb 25 '26 Option Exercise 0.00 6,364 0 64,117 Feb 27 04:04 PM Tornos Ivan Chairman, President and CEO Feb 25 '26 Option Exercise 0.00 19,090 0 78,239 Feb 27 04:03 PM Stellato Paul A VP, Controller, CAO Feb 25 '26 Option Exercise 0.00 820 0 4,929 Feb 27 04:02 PM Phipps Chad F See remarks below. Feb 20 '26 Option Exercise 0.00 2,246 0 63,079 Feb 24 09:03 PM Yi Sang Group President, Asia Pacific Feb 20 '26 Option Exercise 0.00 2,382 0 20,052 Feb 24 09:01 PM VAN ZUILEN WILFRED Group Pres, EMEA Feb 20 '26 Option Exercise 0.00 2,451 0 24,093 Feb 24 09:01 PM Winkler Lori SVP and CHRO Feb 20 '26 Option Exercise 0.00 1,845 0 8,678 Feb 24 09:00 PM Stellato Paul A VP, Controller, CAO Feb 20 '26 Option Exercise 0.00 701 0 4,471 Feb 24 08:59 PM Tornos Ivan Chairman, President and CEO Feb 20 '26 Option Exercise 0.00 15,996 0 67,995 Feb 24 08:58 PM Upadhyay Suketu Exec VP, CFO Feb 20 '26 Option Exercise 0.00 5,445 0 60,199 Feb 24 08:58 PM Yi Sang Group President, Asia Pacific Feb 12 '26 Sale 96.49 1,000 96,490 17,670 Feb 17 04:07 PM Yi Sang Officer Feb 12 '26 Proposed Sale 96.49 1,000 96,490 Feb 12 12:05 PM Winkler Lori SVP and CHRO Nov 28 '25 Option Exercise 0.00 179 0 6,956 Dec 03 04:16 PM Upadhyay Suketu Exec VP, CFO Nov 10 '25 Option Exercise 0.00 10,632 0 59,485 Nov 12 04:07 PM
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
President Mr. Ivan Tornos
Group President of Europe Mr. Wilfred van Zuilen
Senior VP Mr. JehanZeb Noor
Interim CFO Mr. Paul A. Stellato
Senior VP & Chief Information and Technology Officer Mr. Shaun Braun